Related Experiment Videos

Regulation of amino acid-sensitive TOR signaling by leucine analogues in adipocytes

C J Lynch1, H L Fox, T C Vary

  • 1Department of Cellular and Molecular Physiology, Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033, USA. clynch@psu.edu

Insights

L-leucine activates the target of rapamycin (TOR) signaling pathway in adipocytes. Researchers identified key structural features of leucine necessary for activating TOR signaling, differentiating this site from other leucine-binding proteins.

Area of Science:

  • Cellular signaling
  • Molecular biology
  • Biochemistry

Background:

  • Amino acids, particularly L-leucine, stimulate the target of rapamycin (TOR) signaling pathway in adipocytes.
  • TOR signaling regulates crucial cellular processes, including protein synthesis, via phosphorylation of targets like 4E-BP1 and S6.
  • Understanding the specific L-leucine recognition site (LeuR(A)) is key to elucidating nutrient-sensing mechanisms in adipocytes.

Purpose of the Study:

  • To analyze the structure-activity relationships of the L-leucine recognition site (LeuR(A)) in adipocytes that regulates TOR activity.
  • To determine which structural modifications of L-leucine analogues affect their ability to stimulate 4E-BP1 phosphorylation, an indicator of TOR activity.

Main Methods:

  • Examined the effects of various L-leucine analogues on the rapamycin-sensitive phosphorylation of 4E-BP1 in adipocytes.
  • Assessed the potency of different amino acids and leucine analogues in stimulating 4E-BP1 phosphorylation.

Main Results:

  • Several leucine-related amino acids, including norleucine and isoleucine, stimulated 4E-BP1 phosphorylation, with potency order: leucine > norleucine > threo-L-beta-hydroxyleucine ≈ Ile > Met ≈ Val.
  • Weak agonist activity was observed for analogues with modifications to the alpha-hydrogen or small lipophilic R groups.
  • Analogues with modified amino/carboxylic groups, charged R groups, or bulkier aliphatic R groups showed no significant agonist activity.

Conclusions:

  • Small lipophilic modifications to leucine's R group and alpha-hydrogen are tolerated for agonist activity at LeuR(A).
  • The LeuR(A) site appears distinct from other known leucine-binding sites, including those involved in macroautophagy, hepatic TOR signaling, and amino acid transport.

Related Concept Videos